Dr. Ellen Zagrebelsky, MD

NPI: 1275584807
Total Payments
$14,753
2024 Payments
$249.98
Companies
36
Transactions
250
Medicare Patients
3,137
Medicare Billing
$334,156

Payment Breakdown by Category

Food & Beverage$14,675 (99.5%)
Education$78.37 (0.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $14,675 238 99.5%
Education $78.37 12 0.5%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $2,325 24 $0 (2022)
Novo Nordisk Inc $2,019 25 $0 (2023)
Janssen Pharmaceuticals, Inc $1,698 29 $0 (2023)
Amarin Pharma Inc. $928.32 14 $0 (2019)
AbbVie Inc. $842.28 7 $0 (2021)
Allergan Inc. $736.61 18 $0 (2019)
E.R. Squibb & Sons, L.L.C. $639.28 14 $0 (2024)
Novartis Pharmaceuticals Corporation $635.34 14 $0 (2019)
SANOFI-AVENTIS U.S. LLC $616.45 5 $0 (2022)
Amgen Inc. $465.24 7 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $249.98 2 AIMMUNE THERAPEUTICS, INC. ($124.99)
2023 $895.18 9 Amgen Inc. ($249.74)
2022 $763.78 6 Medtronic, Inc. ($160.52)
2021 $1,045 10 AstraZeneca Pharmaceuticals LP ($374.15)
2020 $723.28 10 AstraZeneca Pharmaceuticals LP ($374.64)
2019 $3,134 43 Janssen Pharmaceuticals, Inc ($620.52)
2018 $3,837 70 Novo Nordisk Inc ($1,010)
2017 $4,105 100 AstraZeneca Pharmaceuticals LP ($693.59)

All Payment Transactions

250 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/17/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $124.99 General
Category: Cardiovascular
02/22/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $124.99 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
10/04/2023 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $10.88 General
Category: Cardiovascular
07/18/2023 Intuity Medical Inc Pogo Automatic Blood Glucose Monitoring System (Device) Food and Beverage Cash or cash equivalent $116.59 General
Category: Diabetes
07/13/2023 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $128.87 General
Category: Cardiovascular
06/22/2023 NESTLE HEALTHCARE NUTRITION INC. ZENPEP (Drug) Food and Beverage In-kind items and services $124.99 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
06/14/2023 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $14.12 General
Category: Cardiovascular
04/20/2023 Novo Nordisk Inc Food and Beverage In-kind items and services $125.00 General
03/23/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Cardiovascular & Metabolism
03/16/2023 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $124.74 General
Category: Inflammation
02/15/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $125.00 General
Category: Cardiology
10/24/2022 SANOFI-AVENTIS U.S. LLC TOUJEO (Biological) Food and Beverage In-kind items and services $142.50 General
Category: Endocrine & Metabolic Diseases
10/19/2022 Ironwood Pharmaceuticals, Inc Linzess (Drug) Food and Beverage Cash or cash equivalent $124.76 General
Category: GI
10/05/2022 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Cardiovascular and Metabolism
08/02/2022 Medtronic, Inc. MINIMED 630G (Device) Food and Beverage In-kind items and services $160.52 General
Category: Durable Pump
06/09/2022 Ethicon US, LLC LINX Reflux Management System (Device) Food and Beverage In-kind items and services $97.37 General
Category: Endo-Mechanical
05/11/2022 Esperion Therapeutics, Inc. NEXLIZET (Drug), NEXLETOL Food and Beverage In-kind items and services $113.64 General
Category: ANTILIPEMIC AGENTS
12/15/2021 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Cardiovascular & Metabolism
10/28/2021 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $63.00 General
Category: Cardiovascular
10/13/2021 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $12.72 General
Category: Cardiovascular
09/29/2021 Takeda Pharmaceuticals U.S.A., Inc. MOTEGRITY (Drug) Food and Beverage In-kind items and services $124.72 General
Category: INTERNAL MEDICINE
08/24/2021 AbbVie Inc. Food and Beverage In-kind items and services $124.00 General
08/12/2021 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Cardiovascular and Metabolism
08/05/2021 Novo Nordisk Inc RYBELSUS (Drug) Food and Beverage In-kind items and services $124.74 General
Category: Diabetes
07/28/2021 AbbVie Inc. CREON (Drug) Food and Beverage In-kind items and services $96.36 General
Category: ENDOCRINOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 710 1,008 $254,310 $54,442
2022 12 781 1,307 $266,264 $69,879
2021 11 838 1,553 $314,449 $84,144
2020 14 808 1,755 $323,796 $125,691
Total Patients
3,137
Total Services
5,623
Medicare Billing
$334,156
Procedure Codes
48

All Medicare Procedures & Services

48 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 163 284 $80,214 $15,923 19.9%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 32 32 $20,715 $9,038 43.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 128 187 $41,465 $8,491 20.5%
99350 Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes Office 2023 41 132 $43,200 $7,782 18.0%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2023 94 109 $20,256 $4,591 22.7%
99497 Advance care planning, first 30 minutes Office 2023 71 75 $15,699 $2,802 17.8%
90662 Influenza vaccine split virus, preservative free Office 2023 28 28 $3,780 $2,014 53.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 79 79 $20,920 $1,561 7.5%
G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a Office 2023 28 34 $5,049 $1,138 22.5%
G0008 Administration of influenza virus vaccine Office 2023 28 28 $1,540 $897.40 58.3%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 18 20 $1,472 $204.85 13.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 175 342 $83,448 $21,202 25.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 186 352 $67,584 $19,257 28.5%
99350 Established patient home visit, typically 1 hour Office 2022 48 192 $55,328 $8,976 16.2%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2022 101 126 $24,192 $5,528 22.9%
90662 Influenza vaccine split virus, preservative free Office 2022 68 72 $9,000 $4,912 54.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 21 21 $5,901 $3,119 52.9%
G0008 Administration of influenza virus vaccine Office 2022 67 71 $2,840 $2,234 78.7%
90732 Pneumococcal vaccine, 23-valent Office 2022 14 14 $3,125 $1,847 59.1%
G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a Office 2022 37 49 $9,408 $1,624 17.3%
G0009 Administration of pneumococcal vaccine Office 2022 23 23 $828.00 $728.19 87.9%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 30 31 $2,356 $343.81 14.6%
99354 Extended office or other outpatient service, first hour Office 2022 11 14 $2,254 $106.92 4.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 241 693 $141,459 $38,137 27.0%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 132 240 $61,332 $16,370 26.7%

About Dr. Ellen Zagrebelsky, MD

Dr. Ellen Zagrebelsky, MD is a Geriatric Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275584807.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ellen Zagrebelsky, MD has received a total of $14,753 in payments from pharmaceutical and medical device companies, with $249.98 received in 2024. These payments were reported across 250 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($14,675).

As a Medicare-enrolled provider, Zagrebelsky has provided services to 3,137 Medicare beneficiaries, totaling 5,623 services with total Medicare billing of $334,156. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.

Practice Information

  • Specialty Geriatric Medicine
  • Location Philadelphia, PA
  • Active Since 05/16/2006
  • Last Updated 04/13/2015
  • Taxonomy Code 207RG0300X
  • Entity Type Individual
  • NPI Number 1275584807

Products in Payments

  • FARXIGA (Drug) $1,933
  • XARELTO (Drug) $1,038
  • Vascepa (Drug) $928.32
  • Ozempic (Drug) $707.97
  • ELIQUIS (Drug) $705.72
  • INVOKANA (Drug) $660.82
  • ENTRESTO (Drug) $635.34
  • Victoza (Drug) $553.72
  • BYDUREON (Drug) $383.25
  • WATCHMAN (Device) $351.70
  • NAMZARIC (Drug) $324.25
  • Repatha (Biological) $287.93
  • VRAYLAR (Drug) $272.62
  • CAMZYOS (Drug) $264.74
  • ZENPEP (Drug) $249.98
  • TOUJEO (Drug) $249.34
  • Creon (Drug) $248.68
  • Xultophy 100/3.6 (Drug) $242.18
  • Tresiba (Drug) $225.00
  • TRULICITY (Drug) $212.44

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Geriatric Medicine Doctors in Philadelphia